SPL starpharma holdings limited

Significant Radio Diagnostic program delay

  1. 4,204 Posts.
    lightbulb Created with Sketch. 1064
    Wonder what’s going on with the radio-diagnostic program?

    In May 2024 Stapharma stated in the new CEO led Business Review:

    ’Starpharma will prioritise the development of its DEP-HER2 radio-diagnostic program towards a first-in-human clinical study to initiate within the next 12 months.’ (meaning by May 2025).

    Well May 2025 came and went and there has been zero indication/commentary from the company as to the reason for the significant delay or when the human study is likely to commence.

    Not good enough in my opinion.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.